Health Care

SMS Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights

● Sep 7, 2022

Key highlights from SMS Pharmaceuticals Limited (SMSPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: Atul Kothari from Progwell Securities asked about...

Top 5 Stocks with 200% Profit Growth in 2022

● Sep 3, 2022

1. India Cements Ltd India Cements Ltd is a leading cement manufacturing company based in Chennai. It was founded in...

Gufic Biosciences Limited Q1 FY23 Earnings Conference Call Insights

● Sep 2, 2022

Key highlights from Gufic Biosciences Limited (GUFICBIO) Q1 FY23 Earnings Concall Q&A Highlights: Girish Gulati asked about pancreatic cancer update...

Aurobindo Pharma Limited Q1 FY23 Earnings Conference Call Insights

● Sep 2, 2022

Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: [00:08:34] Prakash Agarwal of Axis Capital asked...

Shilpa Medicare Ltd Q1 FY23 Earnings Conference Call Insights

● Aug 31, 2022

Key highlights from Shilpa Medicare Ltd (SHILPAMED) Q1 FY23 Earnings Concall Q&A Highlights: Vineet Gala of Monarch Networth asked about...

Marksans Pharma Limited Q1 FY23 Earnings Conference Call Insights

● Aug 30, 2022

Key highlights from Marksans Pharma Limited (MARKSANS) Q1 FY23 Earnings Concall Management Update: MARKSANS said it aims to increase its...

Zydus Lifesciences Ltd Q1 FY23 Earnings Conference Call Insights

● Aug 24, 2022

Key highlights from Zydus Lifesciences Ltd (ZYDUSLIFE) Q1 FY23 Earnings Concall Q&A Highlights: Neha enquired about the drivers of strong...

Supriya Lifescience Ltd Q1 FY23 Earnings Conference Call Insights

● Aug 23, 2022

Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q1 FY23 Earnings Concall Management Update: SUPRIYA said the company is extending its...

Balaxi Pharmaceuticals Ltd (BALAXI) Q1 FY23 Earnings Concall Transcript

● Aug 18, 2022

Balaxi Pharmaceuticals Ltd (NSE:BALAXI) Q1 FY23 Earnings Concall dated Aug. 18, 2022 Corporate Participants: Ashish Maheshwari — Managing Director Pranav...

SMS Pharmaceuticals Limited (SMSPHARMA) Q2 FY23 Earnings Concall Transcript

● Aug 18, 2022

SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Q2 FY23 Earnings Concall Aug. 18, 2022 Corporate Participants: P. Vamsi Krishna — Executed Director LakshminarayanaTammineedi...